Successful antiviral treatment of chronic hepatitis C leads to a rapid decline of liver stiffness without an early effect on spleen stiffness
Wim Verlinden, Sven Francque, Peter Michielsen, Thomas Vanwolleghem – 26 April 2016
Hepatitis C genotype 4R resistance‐associated polymorphisms: The achilles heel of the nonstructural 5A inhibitors?
Philippe Halfon, Sofiane Mohamed, Guillaume Penaranda, Hacène Khiri, Laurent Chiche, Carine Nicolas, Armand Abergel – 26 April 2016
Intention‐to‐treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list?
Juan J. Araiz, M. Trinidad Serrano, Francisco A. García‐Gil, Elena M. Lacruz, Sara Lorente, José I. Sánchez, Miguel A. Suarez – 26 April 2016 – In human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients, the accelerated severity of liver disease, associated comorbidities, and mortality on the waiting list could change the possibility and results of liver transplantation (LT). Intention‐to‐treat survival analysis (ITTA) can accurately estimate the applicability and efficacy of LT.
Hepatitis C management in prisons: An insight into daily clinical practice in three major Italian correctional houses
Antonella Foschi, Maddalena Casana, Anna Radice, Roberto Ranieri, Antonella d'Arminio Monforte – 26 April 2016
Cholangiocarcinoma risk factors and the potential role of aspirin
Fabio Bagante, T. Clark Gamblin, Timothy M. Pawlik – 26 April 2016
The effect of cirrhosis on radiogenomic biomarker's ability to predict microvascular invasion and outcome in hepatocellular carcinoma
Haiyun Tang, Harrison X. Bai, Chang Su, Ashley M. Lee, Li Yang – 26 April 2016
Reply
Veronica Miller, Patrick Harrington, Anita Howe, Tara Kieffer, Johan Lennerstrand, Oliver Lenz, Erik Lontok, Fiona McPhee, Hongmei Mo, Neil Parkin, Tami Pilot‐Matias – 26 April 2016
Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management
Delphine Nicolle, Monique Fabre, Marina Simon‐Coma, Aurore Gorse, Roland Kappler, Lara Nonell, Mar Mallo, Hazar Haidar, Olivier Déas, Charlotte Mussini, Catherine Guettier, Marie‐José Redon, Laurence Brugières, Maria Rosa Ghigna, Elie Fadel, Louise Galmiche‐Rolland, Christophe Chardot, Jean‐Gabriel Judde, Carolina Armengol, Sophie Branchereau, Stefano Cairo – 26 April 2016 – Identification of new treatments for relapsing pediatric cancer is an unmet clinical need and a societal challenge.